Vitality Biopharma Receives DEA Renewal for Cannabinoid Pharma Development Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/12/2026

1. ORCL
2. ADBE
3. SPY
4. RH
5. CPRT
6. ACVA
7. SEDG
8. QQQ
9. TENB
10. SPCX

Go back to Vitality Biopharma Receives DEA Renewal for Cannabinoid Pharma Development Program
(NASDAQ: VBIO) Delayed: 2.26 +0.06 (2.73%)
Previous Close $2.20    52 Week High $1.84 
Open $2.19    52 Week Low $0.61 
Day High $2.39    P/E N/A 
Day Low $2.17    EPS $0.00 
Volume 160,986